Fig. 2From: Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemiaCombinations of mutations state of TET2, SRSF2, ASXL1 and SETBP1 according ASXL1 mutation in 145 patients with CMMLBack to article page